DLA Piper's '$60m' litigator goes in-house with Pfizer role
DLA Piper's star co-head of mass tort and class actions Amy Schulman has left the firm to join Pfizer as general counsel and senior vice president, it was announced today (28 May). Schulman is renowned as one of the US's top litigators after a Harvard Business School case study in 2006 claimed that she was responsible for a $60m (£30.9m) book of business. Schulman is also believed to have been DLA Piper's highest-paid partner in 2006, earning $5.75m (£2.96m) according to Legal Week's US sister title The American Lawyer.
This premium content is reserved for
Legal Week Subscribers.
A PREMIUM SUBSCRIPTION PROVIDES:
- Trusted insight, news and analysis from the UK and across the globe
- Connections to senior business lawyers within the leading law firms and legal departments
- Optimized access on all of your devices: desktop, tablet and mobile
- Complete access to the site's full archive of more than 56,000 articles
Already have an account? Sign In Now